Published in Allergy on June 20, 2007
Research needs in allergy: an EAACI position paper, in collaboration with EFA. Clin Transl Allergy (2012) 0.97
Development and validation of a 5-day-ahead hay fever forecast for patients with grass-pollen-induced allergic rhinitis. Int J Biometeorol (2013) 0.91
The status quo and unmet needs in the management of allergic rhinitis and chronic rhinosinusitis: a Malaysian perspective. Asia Pac Allergy (2014) 0.87
Patient perceptions of allergic rhinitis and quality of life: findings from a survey conducted in europe and the United States. World Allergy Organ J (2008) 0.86
Explorative study on patient's perceived knowledge level, expectations, preferences and fear of side effects for treatment for allergic rhinitis. Clin Transl Allergy (2012) 0.85
Diode laser treatment in therapy-resistant allergic rhinitis: impact on nasal obstruction and associated symptoms. Lasers Med Sci (2010) 0.84
Perceived triggers of asthma: key to symptom perception and management. Clin Exp Allergy (2013) 0.82
Specific immunotherapy-indications and mode of action. Dtsch Arztebl Int (2013) 0.81
Underdiagnosed and Undertreated Allergic Rhinitis in Urban School-Aged Children with Asthma. Pediatr Allergy Immunol Pulmonol (2014) 0.80
5-grass pollen tablets achieve disease control in patients with seasonal allergic rhinitis unresponsive to drugs: a real-life study. J Asthma Allergy (2013) 0.79
Testing for allergic disease: parameters considered and test value. BMC Fam Pract (2008) 0.78
UK prescribing practices as proxy markers of unmet need in allergic rhinitis: a retrospective observational study. NPJ Prim Care Respir Med (2016) 0.77
Escaping the trap of allergic rhinitis. Clin Mol Allergy (2015) 0.76
[Allergic rhinitis and its impact on asthma (ARIA update 2008). The Austrian perspective]. Wien Med Wochenschr (2009) 0.76
Can Twitter Be a Source of Information on Allergy? Correlation of Pollen Counts with Tweets Reporting Symptoms of Allergic Rhinoconjunctivitis and Names of Antihistamine Drugs. PLoS One (2015) 0.75
Exogenous lipid pneumonia related to long-term use of Vicks VapoRub® by an adult patient: a case report. BMC Ear Nose Throat Disord (2016) 0.75
Authorised allergen products for intracutaneous testing may no longer be available in Germany: Allergy textbooks have to be re-written. Allergo J Int (2015) 0.75
Medication-related costs of rhinitis in Australia: a NostraData cross-sectional study of pharmacy purchases. J Asthma Allergy (2017) 0.75
Seasonal patterns of oral antihistamine and intranasal corticosteroid purchases from Australian community pharmacies: a retrospective observational study. Pragmat Obs Res (2017) 0.75
Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen). Allergy (2008) 12.35
Role of nonallergic hypersensitivity reactions in children with chronic urticaria. Allergy (1998) 3.20
Practical guide to skin prick tests in allergy to aeroallergens. Allergy (2011) 2.51
Unmet clinical needs in chronic spontaneous urticaria. A GA²LEN task force report. Allergy (2010) 2.34
Allergic Rhinitis and its Impact on Asthma (ARIA): achievements in 10 years and future needs. J Allergy Clin Immunol (2012) 2.17
Assessment of histamine-releasing activity of sera from patients with chronic urticaria showing positive autologous skin test on human basophils and mast cells. Clin Exp Allergy (2004) 2.13
Chronic rhinosinusitis in Europe--an underestimated disease. A GA²LEN study. Allergy (2011) 2.13
GA(2)LEN skin test study I: GA(2)LEN harmonization of skin prick testing: novel sensitization patterns for inhalant allergens in Europe. Allergy (2009) 1.72
A case-control study of the relation between plasma selenium and asthma in European populations: a GAL2EN project. Allergy (2008) 1.66
Night-time sedating H1 -antihistamine increases daytime somnolence but not treatment efficacy in chronic spontaneous urticaria: a randomized controlled trial. Br J Dermatol (2014) 1.60
Insulin allergy: clinical manifestations and management strategies. Allergy (2008) 1.56
C3a and C5a stimulate chemotaxis of human mast cells. Blood (1997) 1.55
How to assess disease activity in patients with chronic urticaria? Allergy (2008) 1.55
Mast cells. Int J Dermatol (1995) 1.52
GA(2)LEN skin test study II: clinical relevance of inhalant allergen sensitizations in Europe. Allergy (2009) 1.51
Effects of a pseudoallergen-free diet on chronic spontaneous urticaria: a prospective trial. Allergy (2009) 1.49
Allergen extract-induced interleukin-10 in human memory B cells inhibits immunoglobulin E production. Clin Exp Allergy (2009) 1.47
Food allergy and non-allergic food hypersensitivity in children and adolescents. Clin Exp Allergy (2004) 1.45
Viruses and bacteria in acute asthma exacerbations--a GA² LEN-DARE systematic review. Allergy (2010) 1.45
Risk of first-generation H(1)-antihistamines: a GA(2)LEN position paper. Allergy (2010) 1.42
Standard skin prick testing and sensitization to inhalant allergens across Europe--a survey from the GALEN network. Allergy (2005) 1.25
Development and implementation of guidelines in allergic rhinitis – an ARIA-GA2LEN paper. Allergy (2010) 1.24
Allergic rhinitis management pocket reference 2008. Allergy (2008) 1.23
MeDALL (Mechanisms of the Development of ALLergy): an integrated approach from phenotypes to systems medicine. Allergy (2011) 1.22
GA2LEN (Global Allergy and Asthma European Network) addresses the allergy and asthma 'epidemic'. Allergy (2009) 1.22
Important research questions in allergy and related diseases: nonallergic rhinitis: a GA2LEN paper. Allergy (2008) 1.20
Up-dosing with bilastine results in improved effectiveness in cold contact urticaria. Allergy (2013) 1.09
Important research questions in allergy and related diseases: 3-chronic rhinosinusitis and nasal polyposis - a GALEN study. Allergy (2009) 1.08
The German version of the Chronic Urticaria Quality-of-Life Questionnaire: factor analysis, validation, and initial clinical findings. Allergy (2009) 1.07
Chronic urticaria: an internet survey of health behaviours, symptom patterns and treatment needs in European adult patients. Br J Dermatol (2008) 1.06
ARIA-suggested drugs for allergic rhinitis: what impact on quality of life? A GA2LEN review. Allergy (2008) 1.05
Successful treatment of cholinergic urticaria with anti-immunoglobulin E therapy. Allergy (2008) 1.04
GA2LEN skin test study III: minimum battery of test inhalent allergens needed in epidemiological studies in patients. Allergy (2009) 1.03
Ragweed sensitization in Europe - GA(2)LEN study suggests increasing prevalence. Allergy (2009) 0.99
Efficacy of desloratadine in intermittent allergic rhinitis: a GA(2)LEN study. Allergy (2009) 0.99
Personalized pollen-related symptom-forecast information services for allergic rhinitis patients in Europe. Allergy (2013) 0.98
Recommendations for assessing patient-reported outcomes and health-related quality of life in clinical trials on allergy: a GA(2)LEN taskforce position paper. Allergy (2009) 0.98
Methodology for development of the Allergic Rhinitis and its Impact on Asthma guideline 2008 update. Allergy (2008) 0.97
Specific recommendations for PROs and HRQoL assessment in allergic rhinitis and/or asthma: a GA(2)LEN taskforce position paper. Allergy (2010) 0.97
Acquired cold urticaria: clinical picture and update on diagnosis and treatment. Clin Exp Dermatol (2007) 0.97
Clinical improvement and immunological changes in atopic dermatitis patients undergoing subcutaneous immunotherapy with a house dust mite allergoid: a pilot study. Clin Exp Allergy (2007) 0.96
Expression and functional activity of the IL-8 receptor type CXCR1 and CXCR2 on human mast cells. J Immunol (1998) 0.96
Severe chronic allergic (and related) diseases: a uniform approach--a MeDALL--GA2LEN--ARIA position paper. Int Arch Allergy Immunol (2012) 0.96
How to design and evaluate randomized controlled trials in immunotherapy for allergic rhinitis: an ARIA-GA(2) LEN statement. Allergy (2011) 0.95
Eosinophilic nasal polyps are a rich source of eotaxin, eotaxin-2 and eotaxin-3. Rhinology (2006) 0.95
The impact of GINA suggested drugs for the treatment of asthma on Health-Related Quality of Life: a GA(2)LEN review. Allergy (2008) 0.95
The relation between paracetamol use and asthma: a GA2LEN European case-control study. Eur Respir J (2008) 0.94
Quantitative detection of soluble adhesion molecules in sera of melanoma patients correlates with clinical stage. Dermatology (1996) 0.93
Prevention and control of childhood asthma and allergy in the EU from the public health point of view: Polish Presidency of the European Union. Allergy (2012) 0.93
A combination of wheat flour, ethanol and food additives inducing FDEIA. Allergy (2002) 0.92
Evaluation of systemic provocation tests in patients with suspected allergic and pseudoallergic drug reactions. Acta Derm Venereol (1999) 0.91
Successful treatment of solar urticaria with anti-immunoglobulin E therapy. Allergy (2008) 0.91
Allergic rhinitis: prevalence and possible risk factors in a Gulf Arab population. Allergy (2009) 0.90
Prevention of signs and symptoms of dermographic urticaria by single-dose ebastine 20 mg. Clin Exp Dermatol (2009) 0.90
Primary care: the cornerstone of diagnosis of allergic rhinitis. Allergy (2008) 0.89
Topical sodium cromoglicate relieves allergen- and histamine-induced dermal pruritus. Br J Dermatol (2009) 0.89
Chronic urticaria: a patient survey on quality-of-life, treatment usage and doctor-patient relation. Allergy (2009) 0.89
Evidence-based (S3) guideline on topical corticosteroids in pregnancy. Br J Dermatol (2011) 0.88
Recommendations for assessing patient-reported outcomes and health-related quality of life in patients with urticaria: a GA(2) LEN taskforce position paper. Allergy (2011) 0.88
Pharmacovigilance of drug allergy and hypersensitivity using the ENDA-DAHD database and the GALEN platform. The Galenda project. Allergy (2009) 0.88
The transcription factor profile of human mast cells in comparison with monocytes and granulocytes. Cell Mol Life Sci (2005) 0.87
Chronic idiopathic urticaria (CIU) is no longer idiopathic: time for an update. Br J Dermatol (2013) 0.86
Ethanol as a cause of hypersensitivity reactions to alcoholic beverages. Clin Exp Allergy (2002) 0.86
Management of chronic spontaneous urticaria in real life--in accordance with the guidelines? A cross-sectional physician-based survey study. J Eur Acad Dermatol Venereol (2011) 0.84
GM-CSF downmodulates c-kit, Fc(epsilon)RI(alpha) and GM-CSF receptor expression as well as histamine and tryptase levels in cultured human mast cells. Arch Dermatol Res (2001) 0.84
Antihistamine-resistant urticaria factitia successfully treated with anti-immunoglobulin E therapy. Allergy (2010) 0.84
Muckle-Wells syndrome: clinical and histological skin findings compatible with cold air urticaria in a large kindred. Br J Dermatol (2004) 0.84
Efficacy and safety of the interleukin-1 antagonist rilonacept in Schnitzler syndrome: an open-label study. Allergy (2012) 0.83
Spreading excellence in allergy and asthma: the GA2 LEN (Global Allergy and Asthma European Network) project. Allergy (2005) 0.83
European Union meets the challenge of the growing importance of allergy and asthma in Europe. Allergy (2004) 0.83
Pseudoallergic reactions in chronic urticaria are associated with altered gastroduodenal permeability. Allergy (2004) 0.83
Important questions in allergy: novel research areas. Allergy (2008) 0.83
Human mast cells produce and differentially express both soluble and membrane-bound stem cell factor. Scand J Immunol (1999) 0.83
Clinical relevance is associated with allergen-specific wheal size in skin prick testing. Clin Exp Allergy (2014) 0.83
Risk factors of adverse reactions to food in German adults. Clin Exp Allergy (2009) 0.83
Expression of mast cell growth modulating and chemotactic factors and their receptors in human cutaneous scars. J Invest Dermatol (2001) 0.82
The human mast cell line HMC-1 binds and responds to C3a but not C3a(desArg). Scand J Immunol (1998) 0.82
[ARIA (Allergic Rhinitis and its Impact on Asthma) achievements in 10 years and future needs]. Tuberk Toraks (2012) 0.82
Adaptation and initial results of the Polish version of the GA(2)LEN chronic urticaria quality of life questionnaire (CU-Q(2)oL). J Dermatol Sci (2011) 0.82
Impact of native, heat-processed and encapsulated hazelnuts on the allergic response in hazelnut-allergic patients. Clin Exp Allergy (2008) 0.82
The CONSORT statement checklist in allergen-specific immunotherapy: a GA2LEN paper. Allergy (2009) 0.81
Clinical relevance of food additives in adult patients with atopic dermatitis. Clin Exp Allergy (2000) 0.81
Allergen-mediated modulation of CD23 expression is interferon-gamma and interleukin-10 dependent in allergic and non-allergic individuals. Clin Exp Allergy (2003) 0.81
Skin involvement as the first manifestation of systemic aspergillosis in patients after allogeneic hematopoietic cell transplantation. Bone Marrow Transplant (2001) 0.80
Serum manganese superoxide dismutase is a new tumour marker for malignant melanoma. Melanoma Res (1995) 0.80
Nerve growth factor-beta induces mast-cell marker expression during in vitro culture of human umbilical cord blood cells. Immunology (2000) 0.80
Increased leukotriene production by food additives in patients with atopic dermatitis and proven food intolerance. Clin Exp Allergy (2001) 0.79
What we should learn from the London Olympics. Curr Opin Allergy Clin Immunol (2013) 0.79
Mast cell and myeloid marker expression during early in vitro mast cell differentiation from human peripheral blood mononuclear cells. J Invest Dermatol (2000) 0.79
Skin prick tests to common allergens in adult atopic eczema and rhinitis patients: reproducibility on duplicate and repeated testing. Dermatology (1993) 0.79
Type I sensitization towards patent blue as a cause of anaphylaxis. Allergy (2003) 0.78
Tamoxifen counteracts the allergic immune response and improves allergen-induced dermatitis in mice. Clin Exp Allergy (2010) 0.78
Decreased cutaneous expression of stem cell factor and of the p75NGF receptor in urticaria. Br J Dermatol (2003) 0.78
Gelatin-induced urticaria and anaphylaxis after tick-borne encephalitis vaccine. Acta Derm Venereol (2000) 0.78
Results and relevance of critical temperature threshold testing in patients with acquired cold urticaria. Br J Dermatol (2009) 0.78
Impact of early diagnosis and control of chronic respiratory diseases on active and healthy ageing. A debate at the European Union Parliament. Allergy (2013) 0.78
Recommendations for the allergy management in the primary care. Allergy (2014) 0.77
[GA2LEN (Global Allergy and Asthma European Network)]. Rev Mal Respir (2009) 0.77
Allergic sensitization to native and heated celery root in pollen-sensitive patients investigated by skin test and IgE binding. Int Arch Allergy Immunol (1996) 0.77